We are live on
!
Find out more
WVP
Worth Venture Partners Portfolio holdings
AUM
$31.6M
1-Year Est. Return
28.5%
This Fund
S&P 500
This Quarter
Est. Return
+1.67%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$163M
AUM Growth
-$6.83M
(-4%)
Cap. Flow
-$37.1M
Cap. Flow
% of AUM
-22.75%
Top 10 Holdings %
Top 10 Hldgs %
30.94%
Holding
192
New
47
Increased
35
Reduced
23
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adtran
ADTN
|
+$6.46M |
| 2 |
indie Semiconductor
INDI
|
+$2.74M |
| 3 |
Silicom
SILC
|
+$2.7M |
| 4 |
SEV
Sono Group N.V. Common Shares
SEV
|
+$2.6M |
| 5 |
TELA Bio
TELA
|
+$2.22M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CYBE
Cyberoptics Corp
CYBE
|
+$3.74M |
| 2 |
CTO
CTO Realty Growth
CTO
|
+$865K |
| 3 |
SCPH
scPharmaceuticals
SCPH
|
+$788K |
| 4 |
A10 Networks
ATEN
|
+$680K |
| 5 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$640K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.41% |
| 2 | Healthcare | 15.13% |
| 3 | Consumer Discretionary | 5.61% |
| 4 | Financials | 5.45% |
| 5 | Materials | 2.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCPH
26
DELISTED
scPharmaceuticals
SCPH
| $1.23M | 0.75% |
188,522
-147,463
| -44% | -$788K |
|
27
Apollo Global Management
APO
$72.4B
| $1.18M | 0.72% |
25,439
| – | – |
|
28
SCYNEXIS
SCYX
$48.1M
| $1.18M | 0.72% |
61,326
-8,739
| -12% | -$171K |
|
29
TechTarget
TTGT
$325M
| $1.05M | 0.64% |
17,742
+1,349
| +8% | +$86.7K |
|
|
ICAD
30
DELISTED
iCAD Inc
ICAD
| $933K | 0.57% |
444,486
+63,601
| +17% | +$208K |
|
31
PUT
Incyte
INCY
$24.2B
| $900K | 0.55% |
+26,800
| New | +$1.98M |
|
|
ENV
32
DELISTED
ENVESTNET, INC.
ENV
| $856K | 0.52% |
19,279
-9,826
| -34% | -$524K |
|
33
BK Technologies
BKTI
$300M
| $832K | 0.51% |
69,087
| – | – |
|
|
HZNP
34
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $829K | 0.51% |
+13,400
| New | +$936K |
|
|
ITI
35
DELISTED
Iteris, Inc.
ITI
| $811K | 0.5% |
272,944
| – | – |
|
|
MDNA
36
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
| $799K | 0.49% |
963,801
+392,312
| +69% | +$443K |
|
37
RF Industries
RFIL
$134M
| $740K | 0.45% |
128,684
| – | – |
|
|
APEN
38
DELISTED
Apollo Endosurgery, Inc.
APEN
| $697K | 0.43% |
126,535
+2,135
| +2% | +$11.8K |
|
39
Booking.com
BKNG
$149B
| $647K | 0.4% |
9,850
-25
| -0.3% | -$1.88K |
|
40
Southwest Airlines
LUV
$22B
| $641K | 0.39% |
+20,777
| New | +$778K |
|
41
Sanofi
SNY
$103B
| $630K | 0.39% |
+16,572
| New | +$738K |
|
42
Capital One
COF
$128B
| $614K | 0.38% |
+6,664
| New | +$710K |
|
43
Pixelworks
PXLW
$38.2M
| $614K | 0.38% |
31,775
-7,141
| -18% | -$170K |
|
44
Ideal Power
IPWR
$60.8M
| $547K | 0.34% |
52,888
| – | – |
|
45
Lightpath Technologies
LPTH
$651M
| $545K | 0.33% |
509,425
| – | – |
|
46
Allot
ALLT
$372M
| $533K | 0.33% |
136,062
+553
| +0.4% | +$2.63K |
|
|
NTST
47
NETSTREIT Corp
NTST
$2.09B
| $504K | 0.31% |
28,317
-10,463
| -27% | -$209K |
|
48
Cardlytics
CDLX
$21.7M
| $485K | 0.3% |
5,162
+2,309
| +81% | +$329K |
|
49
Equity Residential
EQR
$24.9B
| $471K | 0.29% |
7,007
+45
| +0.6% | +$3.33K |
|
|
CTO
50
CTO Realty Growth
CTO
$824M
| $437K | 0.27% |
23,302
-41,474
| -64% | -$865K |
|
Similar funds
VL
SP
OGC
PE
RL
AIIC
LGM
SCA
Worth Venture Partners's Q3 2022 Portfolio in Review
As of Q3 2022, Worth Venture Partners held 192 positions worth $163M, down 4% from $170M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Worth Venture Partners withdrew a net $37.1M in Q3 2022, closing 17 positions and reducing 23 holdings. Its most notable exit was Cyberoptics Corp, an estimated $3.74M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Worth Venture Partners opened a new position in Adtran worth $5.8M.
- Worth Venture Partners's largest Q3 2022 buy was Adtran: 296,241 shares worth $5.8M.
- Worth Venture Partners added most to TELA Bio in Q3 2022, an estimated $2.22M increase.
- Worth Venture Partners's biggest Q3 2022 reduction was CTO Realty Growth, cutting an estimated $865K.
- Worth Venture Partners fully exited Cyberoptics Corp in Q3 2022, selling an estimated $3.74M.
- Worth Venture Partners's ten largest holdings make up 31% of its $163M portfolio in Q3 2022.
- Worth Venture Partners opened 47 new positions and closed 17 in Q3 2022.
- Worth Venture Partners's portfolio value fell 4% quarter-over-quarter to $163M.
Based on Worth Venture Partners's 13F filing for Q3 2022, filed 14 Nov 2022.